SMN1 and pancreatic neoplasm: Previous studies demonstrated in mouse models of pancreatic cancer that FAP+/SMA- CAFs affected inflammation and that their enhancement leads to increased CD11b positive myeloid cells and worse prognosis, while FAP-/SMA + CAFs were associated with the decrease of Treg cells, potentially contributing to suppressing tumor progression [34].